SCHEMBL276340

SCHEMBL276340

CCOC(=O)CC(=O)c1ccc([N+](=O)[O-])cc1

nearest known ligand 0.59

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.59
GSK3B P49841 1/20 0.54
MEN1 O00255 3/20 0.52
KMT2A Q03164 3/20 0.52
MAPT P10636 6/20 0.51
KDM4E B2RXH2 2/20 0.51
GAA P10253 3/20 0.50
ALDH1A1 P00352 3/20 0.50
MAPK1 P28482 2/20 0.50
POLB P06746 1/20 0.50
PKM P14618 1/20 0.50
HDAC3 O15379 1/20 0.50
HDAC1 Q13547 1/20 0.50
HDAC2 Q92769 1/20 0.50
NPC1 O15118 1/20 0.49
RAB9A P51151 1/20 0.49
KCNJ1 P48048 1/20 0.49
KCNH2 Q12809 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11811937 0.93 LMNA (0.55) LMNAGSK3BMEN1KMT2AMAPT
SCHEMBL22677722 0.88 GSK3B (0.51) LMNAGSK3BMEN1KMT2AMAPT
SCHEMBL15379288 0.86 GSK3B (0.53) LMNAGSK3BMEN1KMT2AMAPT
SCHEMBL6650881 0.86 MAPT (0.55) LMNAGSK3BMAPTKDM4EALDH1A1
SCHEMBL5474416 0.85 MEN1 (0.59) GSK3BMEN1KMT2AMAPTALDH1A1
SCHEMBL28852443 0.84 NPC1 (0.55) LMNAMEN1KMT2AMAPTKDM4E
SCHEMBL11828535 0.82 MAPT (0.52) LMNAGSK3BMAPTKDM4EALDH1A1
SCHEMBL1110091 0.82 KMT2A (0.62) MEN1KMT2AMAPTGAAALDH1A1
SCHEMBL27519955 0.81 MAPT (0.63) LMNAGSK3BMEN1KMT2AMAPT
SCHEMBL11510574 0.81 GSK3B (0.71) LMNAGSK3BMEN1KMT2AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 254 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111072476-B Method for high-selectivity fluoromethylation of beta-keto ester compounds on oxygen 南京理工大学 2022-10-21 CN claimed
CN-111072476-A β -ketoester compound oxygen high-selectivity monofluoromethylation method 南京理工大学 2020-04-28 CN claimed
CN-102718757-A 2H-1-benzopyran-2-one compounds with alpha-glucosidase inhibitory activity and medicinal composition of 2H-1-benzopyran-2-one compounds UNIV SHENYANG PHARMACEUTICAL 2012-10-10 CN claimed
US-12421187-B2 Dihydrofolate synthase (DHFS) inhibiting agents and methods of making and using same WASHINGTON UNIVERISTY (US) 2025-09-23 US disclosed
EP-3745105-B1 TEMPERATURE DETECTION LABEL AND ARTICLE MANAGEMENT DEVICE USING SAME HITACHI LTD (JP) 2025-08-27 EP disclosed
CN-112209907-B Method for synthesizing dihydrofuran containing 1, 3-indenodione spiro framework by utilizing microchannel reaction device 南京先进生物材料与过程装备研究院有限公司 2025-03-18 CN disclosed
US-12227524-B2 Anti-infective compounds INSTITUT PASTEUR KOREA (KR) 2025-02-18 US disclosed
US-20240400247-A1 TEMPERATURE INDICATOR MANUFACTURING SYSTEM AND TEMPERATURE INDICATOR MANUFACTURING METHOD HITACHI INDUSTRIAL EQUIPMENT SYSTEMS CO., LTD. (JP) 2024-12-05 US disclosed
EP-4431889-A1 TEMPERATURE INDICATOR MANUFACTURING SYSTEM AND TEMPERATURE INDICATOR MANUFACTURING METHOD Hitachi Industrial Equipment Systems Co., Ltd. (JP) 2024-09-18 EP disclosed
US-12085452-B2 Temperature detection ink, temperature detection ink initialization method, temperature indicator, and article management system HITACHI INDUSTRIAL EQUIPMENT SYSTEMS CO., LTD. (JP) 2024-09-10 US disclosed
CN-118619800-A Amino dithioformate compound and preparation method thereof 抚州三和医药化工有限公司 2024-09-10 CN disclosed
US-4637988-A BINDING, ADSORPTION LANTHANIDE CHELATE COMPOUNDS EASTMAN KODAK COMPANY (US) 1987-01-20 US disclosed
EP-0198356-A1 Heat developable light-sensitive material FUJI PHOTO FILM CO., LTD. (JP) 1986-10-22 EP disclosed
US-4607041-A CARDIOTONIC AGENTS FISONS PLC (GB) 1986-08-19 US disclosed
EP-0177033-A2 Heat-developable light-sensitive material FUJI PHOTO FILM CO., LTD. (JP) 1986-04-09 EP disclosed
EP-0169712-A2 New pyrimidine derivatives, processes for preparation thereof and composition containing the same FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1986-01-29 EP disclosed
US-4532248-A Administering 1,4-dihydropyridine derivative exhibiting positive inotropic activity BAYER AKTIENGESELLSCHAFT (DE) 1985-07-30 US disclosed
EP-0059165-B1 METHOD AND DYESTUFFS FOR DYEING CELLULOSICS AND BLENDS THEREOF WITHOUT AFTERWASH CIBA-GEIGY AG (CH) 1985-05-15 EP disclosed
EP-0059165-A1 Method and dyestuffs for dyeing cellulosics and blends thereof without afterwash CIBA-GEIGY AG (CH) 1982-09-01 EP disclosed
US-4336389-A 2-Substituted-4-aryl-5-thiazolecarboxylic acids and their derivatives as safening agents MONSANTO COMPANY (US) 1982-06-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12227524-B2 Anti-infective compounds RABGGTB, ELANE, SERPINB1 LMNA 4132/4885GSK3B 3486/4885MEN1 3685/4885
US-12421187-B2 Dihydrofolate synthase (DHFS) inhibiting agents and methods of making and using same DHFR, DHPS, MTHFD1 LMNA 3293/4885GSK3B 3565/4885MEN1 3295/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.